Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Baxter
Cantor Fitzgerald
Chubb
Harvard Business School
Novartis
Medtronic
Julphar
Daiichi Sankyo
Cerilliant

Generated: January 23, 2018

DrugPatentWatch Database Preview

Hydrochlorothiazide; triamterene - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; triamterene and what is the scope of hydrochlorothiazide; triamterene freedom to operate?

Hydrochlorothiazide; triamterene
is the generic ingredient in four branded drugs marketed by Glaxosmithkline Llc, Ani Pharms Inc, Duramed Pharms Barr, Ivax Sub Teva Pharms, Lannett Holdings Inc, Mylan, Novartis, Sandoz, Vitarine, Mylan Pharms Inc, Am Therap, Apotex Inc, Pliva, Quantum Pharmics, and Watson Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; triamterene. Forty-three suppliers are listed for this compound.
Summary for hydrochlorothiazide; triamterene
Pharmacology for hydrochlorothiazide; triamterene

US Patents and Regulatory Information for hydrochlorothiazide; triamterene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 073449-001 Sep 23, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 075052-001 Jun 18, 1999 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline Llc DYAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 016042-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett Holdings Inc TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 201407-001 Dec 9, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 074701-001 Jun 7, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 072011-001 Jun 17, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Am Therap TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 072022-001 Apr 17, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 074026-001 Apr 26, 1996 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene TABLET;ORAL 071251-001 Apr 17, 1988 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms TRIAMTERENE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 074259-001 Mar 30, 1995 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for hydrochlorothiazide; triamterene

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc MAXZIDE-25 hydrochlorothiazide; triamterene TABLET;ORAL 019129-003 May 13, 1988 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Cipla
UBS
Accenture
Covington
Baxter
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot